Effect of Sacubitril/Valsartan vs Standard Medical Therapies on Plasma NT-proBNP Concentration and Submaximal Exercise Capacity in Patients With Heart Failure and Preserved Ejection Fraction: The PARALLAX Randomized Clinical Trial.

Pieske B, Wachter R, Shah SJ, Baldridge A, Szeczoedy P, Ibram G, Shi V, Zhao Z, Cowie MR, PARALLAX Investigators and Committee members

Open source

DOI
10.1001/jama.2021.18463
Published
2021 Nov 16
Container
JAMA
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1001/jama.2021.18463,
  title = {Effect of Sacubitril/Valsartan vs Standard Medical Therapies on Plasma NT-proBNP Concentration and Submaximal Exercise Capacity in Patients With Heart Failure and Preserved Ejection Fraction: The PARALLAX Randomized Clinical Trial.},
  author = {Pieske B and Wachter R and Shah SJ and Baldridge A and Szeczoedy P and Ibram G and Shi V and Zhao Z and Cowie MR and PARALLAX Investigators and Committee members},
  year = {2021},
  journal = {JAMA},
  doi = {10.1001/jama.2021.18463},
  url = {https://doi.org/10.1001/jama.2021.18463}
}

RIS

TY  - JOUR
TI  - Effect of Sacubitril/Valsartan vs Standard Medical Therapies on Plasma NT-proBNP Concentration and Submaximal Exercise Capacity in Patients With Heart Failure and Preserved Ejection Fraction: The PARALLAX Randomized Clinical Trial.
AU  - Pieske B
AU  - Wachter R
AU  - Shah SJ
AU  - Baldridge A
AU  - Szeczoedy P
AU  - Ibram G
AU  - Shi V
AU  - Zhao Z
AU  - Cowie MR
AU  - PARALLAX Investigators and Committee members
PY  - 2021
JO  - JAMA
DO  - 10.1001/jama.2021.18463
UR  - https://doi.org/10.1001/jama.2021.18463
ER  - 

APA

B, P., R, W., SJ, S., A, B., P, S., G, I., V, S., Z, Z., MR, C., & members, P. I. A. C. (2021). Effect of Sacubitril/Valsartan vs Standard Medical Therapies on Plasma NT-proBNP Concentration and Submaximal Exercise Capacity in Patients With Heart Failure and Preserved Ejection Fraction: The PARALLAX Randomized Clinical Trial.. JAMA. https://doi.org/10.1001/jama.2021.18463

Source records